A dbait molecule against acquired resistance in the treatment of cancer
AssigneesOnxeo, Institut Curie, Inserm (Institut National De La Sante Et De La Recherche Medicale), Centre National De La Recherche Scientifique
InventorsFRANÇOISE BONO, WAEL JDEY, MARIE DUTREIX
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for delaying and/or preventing development of cancer resistant to a cancer therapy agent in a patient based on administration of a Dbait molecule.
Claims17
1-15. (canceled)
A method for delaying development of cancer resistant to a cancer therapy agent in a patient having cancer comprising administering an effective amount of a Dbait molecule and, optionally, a second cancer therapy agent to the patient, thereby delaying development of cancer resistant to a cancer therapy agent.
Dependencies are inferred from the claim text.